We recently confirmed the strong insulin-suppressive effect on BCAA levels in plasma during a euglycemic hyperinsulinemic clamp in healthy, insulin sensitive people with obesity, however, this insulin-suppressive effect was blunted in people with obesity, diagnosed with non-alcoholic fatty liver (NAFL) and/or T2D [56]. The gene discussed is INS; the disease is Obesity.